Under the terms of the agreement, OmegaQuant will provide Guardion with analytic testing and laboratory support services for current and future products.
Guardion Health Sciences Inc. (Houston, TX) has entered into an agreement with OmegaQuant Laboratories (Sioux Falls, SD). Under the terms of the agreement, OmegaQuant will provide Guardion with analytic testing and laboratory support services for current and future products.
“This relationship with OmegaQuant positions us to conduct a variety of research projects around both our current product lines, as well as to evaluate future products for efficacy,” said Bret Scholtes, Guardion’s chief executive officer, in a press release. “While we are still in the early stages of the relationship, we anticipate applying the Omega-3 Index test to advance the science of our current products, including the recently launched Omega Boost 1,200 mg Omega-3 Gel Bites recently launched under the Guardion flagship Viactiv brand.”
“We look forward to launching research projects with Guardion as we have with several top institutions such as Harvard University and the NIH, as well as with multiple healthcare businesses,” added Jason Polreis, OmegaQuant’s chief executive officer. “Our proprietary standardized and validated testing helps organizations and individuals through their doctors better understand blood chemistry and the impact that fatty acid composition may have on overall health.”